Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BRAINSTORM CELL THERAPEUTICS INC. | Interim Chief Financial Officer & Controller | Common Stock | 65.2K | $34.3K | $0.53 | Mar 11, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BCLI | BRAINSTORM CELL THERAPEUTICS INC. | Mar 11, 2024 | 1 | $0 | 4 | Mar 13, 2024 | Interim Chief Financial Officer & Controller |
BCLI | BRAINSTORM CELL THERAPEUTICS INC. | Aug 25, 2021 | 0 | $0 | 3 | Sep 2, 2021 | Interim Chief Financial Officer Exhibit 24-Power of Attorney |